Wide-Antral Pulmonary Vein Isolation in Atrial Fibrillation Ablation with a Single-shot Technique (WIDER-PVI)

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 440 participants.

Also called NCT06698159

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 440 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06698159
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Italy, Spain (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06698159. Randomized; double masking; primary purpose treatment. Start 2024-11-01 (actual); primary completion 2026-05-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Wide-Antral Pulmonary Vein Isolation in Atrial Fibrillation Ablation with a Single-shot Technique (WIDER-PVI)
Acronym
WIDER-PVI
Condition
Atrial Fibrillation (Paroxysmal)
Intervention (Device)
Cryoablation with cryoballoon 28 mm
Intervention (Device)
Cryoablation with cryoballoon 31 mm
Lead sponsor
Hospital Universitario 12 de Octubre (class: other)

Record details

Record id
cardio:ct-nct06698159
Content hash
69d81f51871fbfee7b1577d4802972f7dc8ec0bb0d07d437177ec11331584da8